A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

So far, Altmetric has seen 6 tweets from 6 users, with an upper bound of 4,346 followers.

A critical appraisal of ibrutinib in treatment of mantle cell lymphoma and chronic lymphocytic leukemia http://t.co/XY6FZZWrq7 @MCLPlymouth

A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and… http://t.co/SyaKdIN6jc #leukemia http://t.co/vsiuntMS5j

Ibrutinib for MCL and CLL http://t.co/YUl4bfiwEl

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 2 additional tweets.